ASCEND BY NTHRYS
Research Abroad Products

Molecular Diagnostics Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Portable CRISPR Testing Kits for Infectious Disease Markets
A commercial product line of field-deployable CRISPR diagnostic kits for rapid detection of emerging infectious diseases in resource-limited settings, field hospitals, and border control applications. Revenue comes from high-volume kit sales to government agencies, NGOs, and international health organizations with licensing opportunities.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
CRISPR Diagnostic Assay Validation and Commercialization Consulting
A specialized consulting service that guides biotech and diagnostic companies through CRISPR assay design, analytical validation, clinical validation, and regulatory approval pathways to market. Revenue is generated through project-based consulting fees, milestone-based success payments, and equity partnerships in commercialization ventures.
CRISPR-Based Molecular Diagnostic Development Click to view more details →
Real-time PCR Panel SaaS for Respiratory Pathogen Detection
A cloud-based diagnostic platform that delivers multiplex PCR assays for rapid identification of influenza, RSV, COVID-19, and other respiratory pathogens with automated result reporting. Enables clinical labs to reduce turnaround time by 60% and increase test throughput, driving higher reimbursement volumes and patient outcomes.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Next-Generation Sequencing NGS Workflow Automation Platform
An integrated software-hardware solution that automates sample preparation, library construction, and bioinformatic analysis for pathogen identification across bacterial, viral, and fungal infections. Reduces manual labor costs by 50% while expanding lab capacity to process 10x more samples monthly without capital equipment investment.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Point-of-Care Molecular Diagnostic Device Platform Software
A connected IoT platform managing rapid molecular tests (LAMP, isothermal amplification) deployed in clinics, urgent care centers, and remote settings with instant cloud synchronization. Generates recurring SaaS revenues through device connectivity subscriptions, data analytics, and telemedicine integration while enabling decentralized diagnostics.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Multiplex Bloodborne Pathogen Detection Cartridge System
A disposable microfluidic cartridge platform that simultaneously detects HIV, hepatitis B, hepatitis C, syphilis, and emerging pathogens from a single blood sample in under 30 minutes. Captures high-volume testing contracts from blood banks, hospitals, and screening centers, generating $50-150 per test with 40% gross margins.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Antimicrobial Resistance Gene Detection and Reporting System
A targeted molecular diagnostic tool identifying resistance genes (beta-lactamase, vancomycin resistance, fluoroquinolone resistance) in cultured isolates with automated stewardship reporting to clinician dashboards. Enables hospitals to implement precision antibiotic therapy, reducing adverse drug events and capturing $20K-50K annual contracts per institution.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Syndromic Multiplex PCR Test Menu Expansion Services
A commercial service offering pre-validated, FDA-cleared multiplex panels for gastrointestinal, respiratory, sepsis, and CNS infections delivered as ready-to-implement assays on customer laboratory platforms. Generates licensing fees, per-test royalties, and reagent sales creating predictable recurring revenue from 500+ hospital and reference lab customers.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Viral Load Quantification and Treatment Monitoring Dashboard
A real-time analytics platform quantifying viral loads (HIV, HCV, SARS-CoV-2) with patient-level trend tracking and treatment response prediction algorithms accessible via mobile and web interfaces. Captures subscription fees from infectious disease clinics and manages recurring monthly monitoring contracts worth $10-30K per clinic annually.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Fungal and Mycobacterial Culture-Independent Identification Kit
A molecular diagnostic kit enabling rapid identification of Mycobacterium tuberculosis, non-tuberculous mycobacteria, and invasive fungi (Candida, Aspergillus, Cryptococcus) without culture, reducing diagnostic time from 6 weeks to 48 hours. Supports high-volume testing contracts with TB programs and immunocompromised patient centers generating $25-75 per test revenue.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Pathogen Detection Data Management and Integration Middleware
An interoperable middleware platform integrating molecular diagnostic results from multiple instruments and assays into centralized LIS/EHR systems with HL7/FHIR compliance and quality control dashboards. Licenses as SaaS to laboratory networks, generating $5-15K monthly per installation plus professional services for deployment and training.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →
Comprehensive Sexually Transmitted Infection Screening Platform
A high-throughput molecular platform performing multiplex nucleic acid amplification testing for gonorrhea, chlamydia, mycoplasma, syphilis, and HPV with automated specimen routing and result delivery to patient portals. Captures contracts with urgent care chains, sexual health clinics, and public health departments generating $15-40 per test with 70%+ gross margins.
Infectious Disease Molecular Diagnostic Platforms Click to view more details →